123 related articles for article (PubMed ID: 1330854)
1. [High affinity binding of Y-25130 for serotonin 3 receptor].
Sakamori M; Takehara S; Setoguchi M
Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):137-42. PubMed ID: 1330854
[TBL] [Abstract][Full Text] [Related]
2. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic activity of Y-25130 on 5-HT3 receptors.
Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
[TBL] [Abstract][Full Text] [Related]
4. High affinity binding of azasetron hydrochloride to 5-hydroxytryptamine3 receptors in the small intestine of rats.
Katayama K; Asano K; Haga K; Fukuda T
Jpn J Pharmacol; 1997 Apr; 73(4):357-60. PubMed ID: 9165374
[TBL] [Abstract][Full Text] [Related]
5. Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
Youssefyeh RD; Campbell HF; Klein S; Airey JE; Darkes P; Powers M; Schnapper M; Neuenschwander K; Fitzpatrick LR; Pendley CE
J Med Chem; 1992 Mar; 35(5):895-903. PubMed ID: 1312602
[TBL] [Abstract][Full Text] [Related]
6. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of GYKI-46 903, a non-competitive ligand at 5-HT3 receptors.
Vitális B; Sebestyén L; Sike M; Sólyom S; Hársing LG
Pharmacol Res; 2001 Mar; 43(3):291-9. PubMed ID: 11401422
[TBL] [Abstract][Full Text] [Related]
9. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
10. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
11. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
12. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
Maksay G
Neuropharmacology; 1998 Dec; 37(12):1633-41. PubMed ID: 9886686
[TBL] [Abstract][Full Text] [Related]
14. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
16. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Rojas C; Stathis M; Thomas AG; Massuda EB; Alt J; Zhang J; Rubenstein E; Sebastiani S; Cantoreggi S; Snyder SH; Slusher B
Anesth Analg; 2008 Aug; 107(2):469-78. PubMed ID: 18633025
[TBL] [Abstract][Full Text] [Related]
17. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
[TBL] [Abstract][Full Text] [Related]
18. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
20. Identification of 5-HT3 recognition sites in the ferret area postrema.
Barnes NM; Costall B; Naylor RJ; Tattersall FD
J Pharm Pharmacol; 1988 Aug; 40(8):586-8. PubMed ID: 2907019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
